FFA
FHTX icon

Farther Finance Advisors’s Foghorn Therapeutics FHTX Stock Holding History

Farther Finance Advisors’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$317 Buy
65
+56
+622% +$249 ﹤0.01% 5625
2026
Q1 		$44 Buy
+9
New +$49 ﹤0.01% 5587

Other funds holding FHTX

DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors's FHTX Position: Q2 2026 in Review

Farther Finance Advisors increased its Foghorn Therapeutics (FHTX) stake by 622% in Q2 2026, buying an estimated $249 and bringing the position to 65 shares worth $317. The position accounts for ﹤0.01% of the portfolio, ranked #5625.

Farther Finance Advisors first reported a position in FHTX in Q1 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Farther Finance Advisors held 65 shares of Foghorn Therapeutics worth $317 as of Q2 2026.
  • Farther Finance Advisors bought 56 Foghorn Therapeutics shares in Q2 2026, an estimated $249.
  • Foghorn Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5625 holding.
  • Farther Finance Advisors first reported a position in Foghorn Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 4 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.